Helga Simon-Molas

6PUBLICATIONS
25CO-AUTHORS
Haematological tumoursLiquid biopsiesMolecular targetsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 03, 2025
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

Chaja F Jacobs, Fleur S Peters, Elena Camerini

|Feb 12, 2025
Mitigating T-cell mitochondrial dysfunction in CLL to augment CAR T-cell therapy: evaluation in an immunocompetent model.

Wael Gamal, Nienke B Goedhart, Helga Simon-Molas

|Aug 08, 2023
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia.

Chiara Montironi, Chaja F Jacobs, Gaspard Cretenet

|Apr 29, 2022
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment.

Zhenghao Chen, Helga Simon-Molas, Gaspard Cretenet

|Feb 15, 2022
The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells.

Helga Simon-Molas, Cristina Sánchez-de-Diego, Àurea Navarro-Sabaté

|Feb 14, 2018
PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.

Helga Simon-Molas, Claudia Arnedo-Pac, Pere Fontova

Pageof 1

Frequent Collaborators

4 joint publications

Arnon P Kater

4 joint publications

Fleur S Peters

3 joint publications

Eric Eldering

3 joint publications

Michel van Weeghel